Edesa Biotech EDSA
NASDAQ EDSA
$2.89 +0.04 (+1.40%)
As of: Oct 22, 2026 · 9:30 AM EDT

Edesa Biotech (EDSA) Share-based Compensation (2013 - 2026)

Updated

Edesa Biotech (EDSA) posted Share-based Compensation of $399,862 for fiscal Q1 2026 (quarter ended Dec 31, 2025), up 392.5% from $81,183 a year earlier but down 1.1% from the prior quarter.

Analysis

Edesa Biotech (EDSA) Share-based Compensation (2013 - 2026) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, Share-based Compensation at Edesa Biotech was $1.05 million, up 141.4% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $729,642, up 35.7% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • In prior fiscal years, Edesa Biotech's Share-based Compensation was $537,492 in FY2024 (-56.9%), $1.25 million in FY2023 (-44.9%), $2.26 million in FY2022 (-29.3%) and $3.2 million in FY2021 (+434.0%).
  • Quarterly Share-based Compensation has run from a low of $66,653 in fiscal Q2 2025 to a high of $1.1 million in fiscal Q3 2021 over five years.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last three quarters, with growth averaging 68.1% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q4 2021, with growth of 947.2%; the weakest was fiscal Q4 2024, with a decline of 81.8%.
  • According to Business Quant data, Share-based Compensation for the three prior fiscal quarters was $404,425 (Q4 2025), $177,381 (Q3 2025) and $66,653 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn 458.00 Mn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn 166.00 Mn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn -
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn -
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 249.00 Mn
10 Edesa Biotech 26.03 Mn -19.51 Mn - 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Dec 31, 2025 400,000.00
Sep 30, 2025 404,425.00
Jun 30, 2025 200,000.00
Mar 31, 2025 66,653.00
Dec 31, 2024 81,183.00
Sep 30, 2024 93,933.00
Jun 30, 2024 100,000.00
Mar 31, 2024 149,696.00
Dec 31, 2023 184,357.00
Sep 30, 2023 517,077.00
Jun 30, 2023 108,159.00
Mar 31, 2023 287,547.00
Dec 31, 2022 333,675.00
Sep 30, 2022 455,964.00
Jun 30, 2022 565,384.00
Mar 31, 2022 630,008.00
Dec 31, 2021 609,278.00
Sep 30, 2021 904,675.00
Jun 30, 2021 1.10 Mn
API Access

Edesa Biotech Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EDSA&period=max&api_key=YOUR_API_KEY